Back to search

Article

An integrative network medicine approach identifies Erlotinib as a repurposed therapeutic candidate for obesity

2026-08-26

Abstract excerpt

<title>Abstract</title> <p> Background Obesity is a complex metabolic disorder characterized by adipose tissue dysfunction, chronic inflammation, and lipid metabolism disorders. Current anti-obesity therapies remain limited by efficacy and safety concerns. Drug repurposing offers an efficient strategy for therapeutic discovery, but cell-type-specific approaches are still lacking. Methods We developed a cell-ty...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16c79adb-d196-5f2c-b35a-5588924749e7
DOI
10.21203/rs.3.rs-10469287/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An integrative network medicine approach identifies Erlotinib as a repurposed therapeutic candidate for obesityDOI 10.21203/rs.3.rs-10469287/v1
Select a neighboring publication to make it the new centre.